Nucleus Software [NUCLEUS] vs Technvision Ventures [TECHNVISN] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Nucleus Software wins in 15 metrics, Technvision Ventures wins in 4 metrics, with 0 ties. Nucleus Software appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricNucleus SoftwareTechnvision VenturesBetter
P/E Ratio (TTM)15.7210,361.11Nucleus Software
Price-to-Book Ratio3.23420.74Nucleus Software
Debt-to-Equity Ratio0.2525.93Nucleus Software
PEG Ratio0.85-105.14Technvision Ventures
EV/EBITDA13.42878.87Nucleus Software
Profit Margin (TTM)19.66%-0.86%Nucleus Software
Operating Margin (TTM)14.05%1.80%Nucleus Software
EBITDA Margin (TTM)14.05%1.80%Nucleus Software
Return on Equity20.02%0.70%Nucleus Software
Return on Assets (TTM)14.14%0.06%Nucleus Software
Free Cash Flow (TTM)$1.36B$76.96MNucleus Software
Dividend Yield1.08%N/AN/A
1-Year Return-20.51%27.43%Technvision Ventures
Price-to-Sales Ratio (TTM)3.0913.97Nucleus Software
Enterprise Value$22.85B$29.71BTechnvision Ventures
EV/Revenue Ratio2.6712.70Nucleus Software
Gross Profit Margin (TTM)33.15%23.81%Nucleus Software
Revenue per Share (TTM)$323$376Technvision Ventures
Earnings per Share (Diluted)$63.52$-3.12Nucleus Software
Beta (Stock Volatility)-0.330.43Nucleus Software
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Nucleus Software vs Technvision Ventures Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Nucleus Software-0.50%-5.24%-2.63%-15.73%23.83%-3.80%
Technvision Ventures0.19%2.11%-19.85%36.25%-20.56%52.94%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Nucleus Software-20.51%151.96%48.17%328.96%623.48%609.85%
Technvision Ventures27.43%2,134.06%2,474.99%2,474.99%2,474.99%2,474.99%

News Based Sentiment: Nucleus Software vs Technvision Ventures

Nucleus Software

News based Sentiment: MIXED

September presented a mixed bag for Nucleus Software, with positive business developments like the Finnovex award and Saarathi Finance partnership being significantly offset by the SEBI penalty for insider trading. While long-term performance remains strong, the governance concerns create uncertainty and require close monitoring, making this a month of both opportunity and risk.

View Nucleus Software News Sentiment Analysis

Technvision Ventures

News based Sentiment: NEGATIVE

September brought a concerning mix of negative developments for Technvision Ventures, including a significant profit decline, stock price drops, and increased selling pressure. While long-term performance remains strong, the short-term headwinds create uncertainty and warrant careful investor attention. The insider sale adds another layer of complexity to the investment story.

View Technvision Ventures News Sentiment Analysis

Performance & Financial Health Analysis: Nucleus Software vs Technvision Ventures

MetricNUCLEUSTECHNVISN
Market Information
Market Cap i₹26.41B₹33.55B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i13,612238
90 Day Avg. Volume i13,347627
Last Close₹998.40₹5,205.35
52 Week Range₹725.00 - ₹1,378.00₹2,949.75 - ₹8,000.00
% from 52W High-27.55%-34.93%
All-Time High₹1,787.50 (Jan 22, 2024)₹8,000.00 (Mar 17, 2025)
% from All-Time High-44.15%-34.93%
Growth Metrics
Quarterly Revenue Growth0.11%0.09%
Quarterly Earnings Growth0.17%-0.99%
Financial Health
Profit Margin (TTM) i0.20%-0.01%
Operating Margin (TTM) i0.14%0.02%
Return on Equity (TTM) i0.20%0.01%
Debt to Equity (MRQ) i0.2525.93
Cash & Liquidity
Book Value per Share (MRQ)₹309.29₹12.37
Cash per Share (MRQ)₹136.33₹87.80
Operating Cash Flow (TTM) i₹2.28B₹27.25M
Levered Free Cash Flow (TTM) i₹1.63B₹1.14M
Dividends
Last 12-Month Dividend Yield i1.08%N/A
Last 12-Month Dividend i₹12.50N/A

Valuation & Enterprise Metrics Analysis: Nucleus Software vs Technvision Ventures

MetricNUCLEUSTECHNVISN
Price Ratios
P/E Ratio (TTM) i15.7210,361.11
Forward P/E i35.47N/A
PEG Ratio i0.85-105.14
Price to Sales (TTM) i3.0913.97
Price to Book (MRQ) i3.23420.74
Market Capitalization
Market Capitalization i₹26.41B₹33.55B
Enterprise Value i₹22.85B₹29.71B
Enterprise Value Metrics
Enterprise to Revenue i2.6712.70
Enterprise to EBITDA i13.42878.87
Risk & Other Metrics
Beta i-0.330.43
Book Value per Share (MRQ) i₹309.29₹12.37

Financial Statements Comparison: Nucleus Software vs Technvision Ventures

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)NUCLEUSTECHNVISN
Revenue/Sales i₹2.18B₹566.16M
Cost of Goods Sold i₹1.46B₹431.36M
Gross Profit i₹721.70M₹134.79M
Research & Development iN/AN/A
Operating Income (EBIT) i₹305.80M₹5.11M
EBITDA i₹519.40M₹18.03M
Pre-Tax Income i₹483.00M₹5.23M
Income Tax i₹131.00M₹4.94M
Net Income (Profit) i₹352.00M₹289,000

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)NUCLEUSTECHNVISN
Cash & Equivalents i₹501.60M₹5.35M
Total Current Assets i₹5.44B₹1.41B
Total Current Liabilities i₹2.83B₹1.35B
Long-Term Debt i₹8.80M₹102.25M
Total Shareholders Equity i₹8.14B₹163.07M
Retained Earnings i₹7.67B₹-3.40M
Property, Plant & Equipment i₹470.30M₹4.62M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)NUCLEUSTECHNVISN
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricNUCLEUSTECHNVISN
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i13,612238
Average Daily Volume (90 Day) i13,347627
Shares Outstanding i26.33M6.28M
Float Shares i6.61M862,087
% Held by Insiders i0.76%0.93%
% Held by Institutions i0.03%0.00%

Dividend Analysis & Yield Comparison: Nucleus Software vs Technvision Ventures

MetricNUCLEUSTECHNVISN
Last 12-Month Dividend i₹12.50N/A
Last 12-Month Dividend Yield i1.08%N/A
3-Year Avg Annual Dividend i₹11.67N/A
3-Year Avg Dividend Yield i0.93%N/A
3-Year Total Dividends i₹35.00N/A
Ex-Dividend DateJul 11, 2025N/A